Press release
$334M Liquidated in 24 Hours and Extreme Fear Just Hit Day 38: What Happens Next Changes Everything
An avalanche of forced selling swept through crypto markets this week, liquidating $334M in leveraged positions within 24 hours. The Fear and Greed index has cratered to 23 and stayed there for 38 consecutive days, the longest extreme fear streak since mid-2022. Altcoins sit near all-time lows. The Fed held rates at 3.50-3.75% while hot PPI printed +0.7%, the largest monthly producer price spike in a year, piling stagflation pressure onto already fragile risk assets. Retail portfolios are buried. Whales see it differently: they accumulated 270,000 BTC worth $23B through the panic, positioning for the reversal that fear eventually creates. Taurox is a decentralized hedge fund built to operate through exactly these conditions. Autonomous AI agents will trade pooled capital across market cycles, routing 80% of gross profits to stakers through a verifiable on-chain fee structure.How the Trading Pool Survives the Avalanche
The Taurox Trading Pool aggregates deposits from stakers into a single capital reserve operated by autonomous agents. Rather than matching one user to one trader, the pool distributes exposure across hundreds of thousands of agents running different strategies in different market conditions. A single agent's underperformance has limited impact because each operates within a capped allocation. Stakers deposit assets and receive txTokens representing their proportional share. Agents will trade the pooled capital continuously across centralized exchanges and decentralized protocols. Net profits accrue to the pool, increasing each txToken's redemption value. When a staker withdraws, they return txTokens for their share of pool assets including accrued returns. The pool maintains a stablecoin reserve buffer, currently set at 15% of total pool capital, for withdrawal liquidity at all times. Stakers keep 80% of gross profits with zero management fees. The pooled model smooths out individual strategy volatility, a structural advantage when avalanche selling buries single-asset holders under concentrated losses.
The Avalanche Missed the Presale Window
Phase 1 of the TAUX presale sold out in under 24 hours at $0.01. Phase 1 buyers are now up 20% at the current Phase 2 price of $0.012. The presale has raised $329.8K, and Phase 2 is 28.8% filled. Each phase has a fixed allocation that closes permanently when sold out. The price steps up to the next tier and the previous entry disappears forever. There are no extensions and no repricing. The market avalanche created a window where most capital is frozen in fear, but the presale keeps filling regardless of broader sentiment. Buying TAUX at lower presale prices secures more pool capacity per dollar than any later phase. Once Phase 2 fills, that ratio shifts permanently against latecomers. Early phases carry the smallest allocations and attract the most concentrated demand. Staking activates at the end of the presale, giving early holders first access to pool yields before public participants enter. Waiting costs real money when every closed phase eliminates the cheapest entry available. Phase 2 is filling. The $0.012 entry closes when the allocation is gone.
Scarcity That Compounds as Fear Fades
Phase 2 is live at $0.012. Listing at $0.08 delivers 6.67x from the current entry. A $1 post-listing price is 100x. At a $1 billion pool with 30% gross returns, implied TAUX price reaches $1.85, or x154. Zero management fees. Performance fees of 5% apply to profits only. Thirty percent of collected fees burn permanently as TAUX. The remaining 70% funds the DAO treasury. Supply is fixed at 2 billion tokens with no minting function. Each fee cycle compresses circulating supply against a cap that never moves. While altcoins sit buried under an avalanche of selling, the presale has raised $329.8K and counting. Full documentation and the whitepaper are at docs.taurox.io. Phase 2 is 28.8% filled and will close when the allocation is exhausted.
Learn More
Buy TAUX: https://taurox.io/
Whitepaper: https://docs.taurox.io/
Official Telegram: https://t.me/tauroxlabs
Contact: Samuel Pierce
Email: Samuel@IgnixMedia.com
Decentralized, non-custodial protocol connecting capital with autonomous trading agents.
Algorithmic allocation. Transparent performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release $334M Liquidated in 24 Hours and Extreme Fear Just Hit Day 38: What Happens Next Changes Everything here
News-ID: 4434772 • Views: …
More Releases from Ignix Media
Every 38-Day Fear Streak in Crypto History Ended the Same Way. Every Single One
The Fear and Greed Index has been pinned below 25 for 38 consecutive days. Every historical streak of this length led to a substantial market rally within the following months. Whale wallets accumulated 270,000 BTC worth $23B during this window, the largest concentration of informed buying since mid-2022. Altcoins are near all-time lows against Bitcoin at 57.1% dominance. The Fed held rates at 3.50-3.75% while hot PPI data showed +0.7%,…
Your Crypto Portfolio in 12 Months Hinges on One Decision You Make This Week
What your portfolio looks like a year from now is being decided right now. The Fear and Greed Index has held below 25 for 38 consecutive days, marking the longest extreme fear streak since mid-2022. Whale wallets loaded 270,000 BTC worth $23B during this window. Altcoins sit near all-time lows against Bitcoin dominance at 57.1%. The Fed held rates at 3.50-3.75%, hot PPI printed +0.7%, and $334M in leveraged longs…
Whales Moved $23B in 38 Days of Fear. Retail Missed the Entire Chess Move
Whale wallets accumulated 270,000 BTC worth $23B over the past 38 days while the Fear and Greed Index held below 25. Retail sold into every red candle. The pattern reads like a chess endgame: one side sacrifices material while the other quietly builds a winning position. Bitcoin dominance climbed to 57.1% as altcoins bled to near all-time lows. The Fed held rates at 3.50-3.75% after hot PPI data printed +0.7%,…
Prediction Models All Flagged This 38-Day Fear Streak. What One Asset Did Next.. …
Every prediction model tracking crypto sentiment has flagged the same anomaly. The Fear and Greed Index has stayed below 25 for 38 consecutive days, the longest extreme fear streak since mid-2022. Whale wallets accumulated 270,000 BTC worth $23B during this window while retail capitulated in waves. The pattern is consistent with historical bottoms where informed capital loads positions and smaller holders sell at the worst possible moment. Liquidation cascades hit…
More Releases for Phase
The Quiet Phase Is Almost Over: BlazPay's Phase 8 Presale Is 90% Sold Out
There's a moment in every successful crypto project that most people miss. It's not the launch. It's not the exchange listing. It's the final stretch of the presale - when the numbers are real, the momentum is visible, and the entry price is about to change forever. BlazPay is at that moment right now.
Phase 8 of the BlazPay presale is 90.4% sold. Over 267 million of 295 million BLAZ tokens…
Single-Phase and Three-Phase Amplifiers: An Innovative Solution to Overcome Sing …
I. Rural Power Grid Upgrades: Solving Power Supply Challenges in Remote AreasChallenges:In remote rural areas, long supply radii and scattered users, combined with single-phase power supply, lead to unstable end-point voltages and insufficient power, making it difficult to meet the electricity demands of modern home appliances and agricultural machinery.Benefits:Improved Voltage Quality: By converting single-phase power into balanced three-phase output, line losses are reduced, resolving the issue of low end-point voltages.Expanded…
Clinical Trials by Phase (Phase I, Phase II, Phase III, Phase IV) Market Forecas …
A clinical trial is a research study, where a group of people is given a test or treatment. Clinical trials study the safety and efficacy of tests and treatments. If the test or treatment is safe and meets regulatory requirements, then it is approved as a standard of care.
Download Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00006203/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
IQVIA
Parexel International Corporation
Charles River Laboratories
ICON plc
SGS SA
Chiltern International Ltd
Syneos Health
PRA Health Sciences
Wuxi AppTec Inc
Pharmaceutical Product Development,…
Digital Phase Shifters Market
Digital Phase Shifters Market A recently identified vacuum in the literature about the creation of digital phase shifters for modern communication systems is attempted to be filled in the book Design of Digital Phase Shifters for Multipurpose Communication Systems. By significantly reducing RF power consumption and improving noise immunity, directed beams enhance the development of new-generation mobile communication systems. In this regard, digital phase shifters in particular, which are part…
COVID-19 - Pipeline Analysis 2020 for Global Market | Emphasis on Products cover …
COVID-19 (also known as Anderson COVID-19)?is a viral disease caused by RNA virus, SARS-CoV-2 or commonly known as corona virus. These viruses can cause respiratory, enteric, hepatic, and neurologic diseases. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China. It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other…
HIV Vaccines Market Perceive Aggrandized Growth at a CAGR of 11.48% Till 2023 | …
HIV Vaccines Market Report Added on MarketResearchFuture.com with Overall Analysis. Key developments and Strategies Cover in this Report. The Market for Expected to Grow Globally Over the CAGR of 5 % During the Period 2018 to 2027 from USD 2,702.3 Billion in 2027.
HIV Vaccines Market - Segmentation
The global HIV vaccines market has been segmented on the basis of basis of antibiotics, type, and lastly, region.
Antibiotics have been segmented into dicloxacillin,…
